乳腺癌的化学抗药性研究:知识映射,热点演变和新兴见解 (1994-2024)
Hao Zhang1,2, Ting Feng3, Juntang Lin4
1Department of Biomedical Sciences, Advanced Medical and Dental Institute (IPPT), Universiti Sains Malaysia, SAINS@Bertam, Kepala Batas, Penang, 13200, Malaysia.
本文对30年来乳腺癌化学抗药性研究进行了图谱分析,重点强调三阴性乳腺癌 (TNBC) 和铁. 未来的方向包括循环RNA和液体活检用于精确治疗.
科学领域:
- 癌症学
- 基因组学
- 生物医学研究
背景情况:
- 化学抵抗是乳腺癌治疗的一个主要障碍.
- 了解全球研究趋势对于开发新疗法至关重要.
研究的目的:
- 系统地分析乳腺癌化学抵抗的全球研究趋势,热点和未来方向.
- 为推进抗化学性乳腺癌治疗策略提供见解.
主要方法:
- 从科学网数据库中对1929篇出版物 (1994-2024) 的图书统计分析.
- 使用Co-Occurrence,CiteSpace和R软件进行数据分析.
- 研究出版物,有影响力的机构,作者,关键词和新兴主题.
主要成果:
- 中国在出版方面领先; 癌症杂志发表的文章最多.
- "三阴性乳腺癌 (TNBC)",耐多克索鲁比"和"乳腺癌干细胞"是主要主题.
- 生物信息学,多组学和铁性向是当前的主流和新的方法.
- "预测生物标志物"和"液体活检"是新兴热点.
- "循环RNA"和"乳腺癌干性"是未来的研究方向.
结论:
- 文献分析揭示了乳腺癌化学抗药性研究的演变.
- 确定了发展精确疗法的关键趋势,当前热点和未来前沿.
- 提供了对抗性机制和处理设计的更深入探索的框架.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
